C&EN: Porous pesticide carrier also promotes plant growth17 February 2023
Metal-organic framework deploys avermectins against citrus mites.
C&EN: Chemists debate how to fuel molecular machines07 February 2023
As researchers develop efficient molecular fuels, they continue to wrestle with the fundamentals of how their machines work.
C&EN: Copolymer could keep catheters bacteria-free01 February 2023
By reducing biofilm formation and bacterial swarming, this polymer may help to avert common infections.
C&EN: Chain-link molecules form flexible networks18 January 2023
Catenated covalent organic frameworks could find use as additives or membranes.
C&EN: Electric molecular motor charges ahead11 January 2023
Oscillating voltage prompts molecular rings to trundle around a circular track.
TESTIMONIALS“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Freelance Science Writer
Author Archives: benbaxter
The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The FDA has finally indicated it will approve the first biosimilar drug for the United States, years after Europe.
Posted in Highlights Comments Off on The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Posted in Highlights Comments Off on The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer